Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Short therapy shows promise for Kids' nightmares and suicide risk

NCT ID NCT06033781

Symptom relief Sponsor: University of Oklahoma Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a brief therapy called CBT-NC in 57 children aged 6-17 who have frequent nightmares and suicidal thoughts. The goal was to see if the therapy could reduce nightmare distress and improve overall mental health. Children were either given the therapy right away or placed on a waitlist, and researchers tracked changes in sleep, mood, and suicide risk.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

57 people

The number who actually took part.

Started

Aug 2023

Finished

Apr 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

6 to 17 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Child must be between ages of 6-17 years 11 months. * Child must report recurrent nightmares that meet Diagnostic and Statistical Manual of Mental Disorders criteria for nightmare disorder. * Child must speak and understand English at no less than a 6-year-old level. * Children on prescribed psychotropic medications must be stable for 30 days prior to enrolling. * Child must have a parent or legal guardian attend study visits with them. * Participants must have access to WIFI/phone data in order to participate in this study and must have an electronic device with a camera enabled. Exclusion Criteria: * Children with a diagnosis of sleep apnea which is not adequately treated. * Children whose receptive/expressive language skills are below a 6-year-old level. * If it is determined that a child is actively suicidal and at imminent risk for self-harm, the family will be notified and referred for immediate care. They will not be eligible for the study until they are deemed stable.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Children, only are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Behavior Suicidal Ideation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Children, only Nightmare Suicidal ideation

Contacts and locations

Locations

  • University of Oklahoma School of Community Medicine

    Tulsa, Oklahoma, 74135, United States

  • University of Tulsa

    Tulsa, Oklahoma, 74104, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.